Pharmaceutical Export Promotion Council (Pharmexcil)

Introduction

The Pharmaceutical Export Promotion Council (Pharmexcil) is the official agency of the Government of India responsible for promoting pharmaceutical exports from the country. Established in 2008 under the Ministry of Commerce & Industry, Pharmexcil serves as a crucial interface between the pharmaceutical industry and the Government, working to enhance India's position in the global pharmaceutical market.

Operating under the administrative control of the Department of Commerce, Pharmexcil has emerged as a pivotal organization representing the Indian pharmaceutical industry at international forums. The council facilitates export activities through various initiatives, market intelligence services, and regulatory guidance, helping Indian pharmaceutical companies expand their global footprint.

Pharmexcil's scope encompasses promotion of exports across various pharmaceutical categories including formulations, bulk drugs, intermediates, herbal products, and Ayush (Ayurveda, Yoga & Naturopathy, Unani, Siddha, and Homeopathy) products. By coordinating efforts between industry stakeholders and government agencies, Pharmexcil works towards creating an enabling environment for pharmaceutical exports from India.

Mission and Vision

Mission

To promote and develop the export of pharmaceutical products from India by creating awareness, identifying new markets, addressing regulatory barriers, and building the capacity of Indian pharmaceutical manufacturers to meet international standards and expectations.

Vision

To establish India as one of the leading pharmaceutical exporters globally, recognized for quality products, competitive pricing, and innovation, contributing significantly to India's economic growth and improving access to affordable medicines worldwide.

Key Objectives

• Promotion of Pharmaceutical Exports: Identifying potential markets and facilitating Indian pharmaceutical companies' entry into these markets through targeted strategies.
• Market Intelligence: Providing members with valuable market information, trade statistics, regulatory updates, and emerging trends in the global pharmaceutical landscape.
• Regulatory Support: Assisting exporters in understanding and complying with regulatory requirements of different countries and regions.
• Trade Facilitation: Organizing business delegations, buyer-seller meets, and participation in international trade fairs to create business opportunities for Indian exporters.
• Industry-Government Interface: Representing industry concerns to relevant government authorities and facilitating policy changes to promote exports.
• Capacity Building: Conducting training programs, workshops, and seminars to enhance the capabilities of pharmaceutical exporters.
• Brand Building: Promoting Indian pharmaceutical products' global image as high-quality and cost-effective solutions.
• Market Diversification: Encouraging exporters to explore and establish presence in emerging and untapped markets.

Organizational Structure

Pharmexcil functions under the guidance of a committee comprising members from the pharmaceutical industry, government officials, and domain experts. The organizational structure includes:

The council operates through its headquarters in Hyderabad, and regional offices in key pharmaceutical clusters including Mumbai, Delhi, Bengaluru, and Ahmedabad to ensure effective service delivery across the country.

Membership

Pharmexcil offers membership to Indian pharmaceutical companies involved in manufacturing and/or exporting pharmaceutical products. Membership categories include:

• Ordinary Members (exporters with significant turnover)
• Associate Members (potential exporters or smaller companies)
• Overseas Members (foreign companies with business interests in India)

Export Scenario and India's Global Position

India is recognized as one of the leading pharmaceutical exporters globally, often referred to as the "Pharmacy of the World" due to its substantial contribution to global medicine supply. Indian pharmaceutical products are exported to over 200 countries, with major markets including the United States, European Union, Africa, and Latin America.

India's pharmaceutical exports have shown consistent growth, driven by factors such as cost competitiveness, skilled workforce, strong manufacturing capabilities, and increasing compliance with international quality standards. The country supplies approximately 50% of Africa's requirement for generics, 40% of generic demand in the US and 25% of all medicine in the UK.

Major Export Categories

• Formulations: Both finished dose forms and bulk drugs
• Active Pharmaceutical Ingredients (APIs): Raw materials for drug manufacturing
• Herbal and Ayush Products: Traditional and natural medicine preparations
• Medical Devices: Equipment and consumables for healthcare
• Surgical Supplies: Instruments and materials used in medical procedures

Key Initiatives and Programs

• Market Development Assistance: Financial support for participating in international trade fairs and exhibitions
• India Pharma Forum: Establishing platforms in key markets to resolve bilateral trade issues and promote Indian products
• Market Access Initiative: Special projects to facilitate entry into regulated markets
• Focus Product Scheme: Promoting specific pharmaceutical product categories in target markets
• Digital Platforms: Web portals and mobile applications providing real-time trade information
• Quality Infrastructure: Programs to help companies upgrade their quality management systems to meet international standards
• Capacity Building Workshops: Specialized training on regulatory requirements, documentation, and market-specific strategies

Challenges and Future Outlook

Current Challenges

• Stringent and evolving regulatory requirements in developed markets
• Increasing competition from other manufacturing hubs like China
• Price pressures in mature markets
• Intellectual property concerns
• Supply chain vulnerabilities, as highlighted during the COVID-19 pandemic
• Need for greater investment in research and innovation to move up the value chain

Future Priorities

• Exploring new markets in Africa, Latin America, and CIS countries
• Focus on complex generics, biosimilars, and niche therapeutic areas
• Enhancing digital capabilities for remote market engagement
• Building resilient supply chains with reduced dependence on single sources
• Leveraging India's strengths in manufacturing for global health security
• Strengthening quality infrastructure and compliance systems
• Promoting traditional medicines and herbal products in new markets

Contact Information

Headquarters

Pharmaceutical Export Promotion Council (Pharmexcil)
Ground Floor, Dr. Reddy's Laboratories Ltd.
Miyapur, Hyderabad - 500049, Telangana, India
Phone: +91-40-23442344
Email: info@pharmexcil.com

Website

For detailed information, statistics, and membership details, visit: www.pharmexcil.com